Who invested in Advantagene?
Advantagene's investors include Massachusetts Life Sciences Center.
United States · Series A startup
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 2 rounds since 2011, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by FinSMEsSEC filing: $14M sold, first sale Aug 2016
From the SEC filings it signed: 3 on the team.
On the board, as filediAlan C. SmithChris C. MartellEdward J. BenzPaul C. ManningSean C. StalfortUdi C. Merav
Advantagene's investors include Massachusetts Life Sciences Center.
Advantagene has raised $15M across 2 rounds since 2011.
Advantagene's most recent round was a Series A of $14M in Sept 2016.
Its most recent round, $14M in Sept 2016, is also its largest on record.
Advantagene's first round on record, in May 2011, was backed by Massachusetts Life Sciences Center.
Advantagene's latest named round is a Series A, in Sept 2016.
Advantagene is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.